Search: onr:"swepub:oai:gup.ub.gu.se/58799" >
Radioiodine treatme...
-
Berg, Gertrud,1944Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences
(author)
Radioiodine treatment for malignant thyroid disease.
- Article/chapterEnglish2006
Publisher, publication year, extent ...
-
2009-07-08
-
Informa UK Limited,2006
Numbers
-
LIBRIS-ID:oai:gup.ub.gu.se/58799
-
https://gup.ub.gu.se/publication/58799URI
-
https://doi.org/10.1080/02841860600617076DOI
Supplementary language notes
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Radioiodine treatment for thyroid disease has been given for half a decade in Sweden. The most common indication for treatment is hyperthyroidism, when iodine uptake is high. The situation in which radioiodine treatment is used in thyroid cancer is less favourable and measures therefore have to be taken to optimize the treatment. Treatment should be performed early in the course of the disease to achieve the highest possible differentiation. Before treatment the iodine and goitrogen intake should be kept low. Stimulation of the thyrocytes by thyroid-stimulating hormone (TSH) should be high. It is conventionally achieved by thyroid hormone withdrawal rendering the patient hypothyroid, or by the recently available recombinant human TSH (rhTSH) which can be recommended for ablation of the thyroid remnant after thyroidectomy and for treatment of metastases in fragile patients unable to undergo hypothyroidism. Finally, stunning--the negative effect of a prior test dose from radioactive iodine--should be avoided.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Göteborgs universitetInstitutionen för kliniska vetenskaper
(creator_code:org_t)
Related titles
-
In:Acta oncologica (Stockholm, Sweden): Informa UK Limited45:8, s. 1041-50284-186X1651-226X
Internet link
Find in a library
To the university's database